Topics
Business & Finance
-
Tuesday - July 8, 2008
First organ-specific diagnostic agent approved in the U.S. in more than a decade:
Primovist® approved in the U.S. for the Detection and Characterization of Liver Lesions
-
Thursday - July 3, 2008
Bayer CropScience strengthens global position in insecticides market:
Insecticide Movento® approved in United States and Canada
Launch of Movento® planned for 2008
-
Wednesday - July 2, 2008
Bayer HealthCare Completes Acquisition of Western OTC Cough and Cold Business of Topsun Science and Technology
Significantly Strengthens Consumer Care Division’s Business in High Growth Chinese OTC Market
-
Friday - June 27, 2008
Bayer at a glance:
New edition of “Names, Figures, Facts”
Service line for free booklet
-
Tuesday - June 24, 2008
Bayer concludes supply and licensing agreements for Yasmin® and YAZ® with Barr for the United States
Appeal of court decision invalidating Yasmin patent will continue / Further growth of Bayer’s Women’s Healthcare Business Unit expected
-
Monday - June 23, 2008
Bayer’s Belford Roxo site near Rio de Janeiro celebrates 50th anniversary of its founding
Bayer plans to invest EUR 100 million in Brazil
Wenning: “Brazil is our biggest market in Latin America”
-
Monday - June 23, 2008
New Bayer technology reduces power consumption and CO2 emissions by 30 percent:
Bayer receives Environmental Award from the Federation of German Industries
Energy-efficient process recycles chlorine from hydrochloric acid / Industrial application in Germany and China / Bayer Management Board member Dr. Plischke: “Increase in energy efficiency brings economic and ecological benefits”
-
Tuesday - June 3, 2008
Bayer HealthCare successfully completes acquisition of Sagmel, Inc.’s OTC Business
Bayer Consumer Care’s Presence in Eastern Europe Significantly Strengthened
-
Wednesday - May 28, 2008
Bundeskartellamt ends lawsuit against Bayer Vital
-
Wednesday - May 14, 2008
First hybrid rice variety worldwide resistant to bacterial leaf blight:
Bayer CropScience launches new high-yielding rice variety in India
-
Tuesday - May 6, 2008
Bayer Schering Pharma to market new low-dose oral contraceptive YAZ® in Europe
-
Friday - April 25, 2008
Werner Wenning at the Bayer AG Annual Stockholders’ Meeting
“2007 was Bayer’s most successful year to date”
Previous year’s record levels and earnings targets exceeded / Dividend to be raised 35 percent to EUR 1.35 / Good start to fiscal 2008 / Bayer Climate Program being implemented and expanded
-
Friday - April 25, 2008
Annual Stockholders' Meeting
"We got off to a very good start in 2008."
Address by Werner Wenning, Chairman of the Board of Management
-
Friday - April 25, 2008
At its Annual Stockholders’ Meeting, Bayer outlines the Bayer Climate Program:
Solutions to climate change
Exhibitions, publications and a new film document the company’s commitment / Integrated measures for climate protection and for dealing with climate change / Lighthouse projects for production processes, commercial buildings and agriculture
-
Thursday - April 24, 2008
Interim report for the first quarter of 2008
Bayer off to an excellent start in 2008
Sales up 2.4 percent to EUR 8,536 million / EBITDA before special items up 9.8 percent to EUR 2,185 million / EBIT before special items up 8.9 percent to EUR 1,497 million / Full-year guidance for CropScience raised / Positive Group forecast confirmed
-
Monday - April 21, 2008
Bayer Challenges Watson and Sandoz U.S. ANDA Filings on Yasmin®
-
Wednesday - April 2, 2008
Bayer HealthCare Affiliate MEDRAD Announces Completion of Subsequent Offering Period for Shares of Possis Medical
Merger to Be Completed Shortly
-
Monday - March 31, 2008
Bayer appeals invalidity ruling on its Yasmin® Patent
Appeal will be heard by the Federal Circuit
-
Wednesday - March 26, 2008
Bayer HealthCare Affiliate MEDRAD Successfully Completes Tender Offer for Shares of Possis Medical; Announces Subsequent Offering Period
Subsequent Offering Period Expires on Tuesday, April 1, 2008
-
Thursday - March 20, 2008
Follicular lymphoma:
Zevalin® Receives Positive CHMP Opinion in Europe for First-Line Consolidation Treatment
Search
Publications
Annual Report 2007
Stockholder's Newsletter
research – The Bayer Scientific Magazine
Sustainable Development Report 2007
Publications Overview
Newsletter
Events
Download Center - Selection